Insider Trading & Ownership of Audentes Therapeutics, Inc.

Location: San Francisco, CA
Summary: The estimated value of insider holdings of Audentes Therapeutics, Inc. is at least $11.8M dollars as of October 31, 2022. Audentes Therapeutics, Inc. is the 10%+ Owner of Taysha Gene Therapies, Inc. and owns shares of Taysha Gene Therapies, Inc. (TSHA) stock worth about $11.8M.
Signature: /s/ Chad Diehl, Attorney-in-Fact, Astellas
All Insider Reports: All Insider Reports

Notify me when Audentes Therapeutics, Inc. files a new Insider Trading report.

Ownership of Audentes Therapeutics, Inc.

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
TSHA	Taysha Gene Therapies, Inc.	10%+ Owner	$11.8M			Oct 21, 2022